Documentos relacionados

1. Generic Medicinal Products in Immunosuppressive Therapy-Should It be a Challenge for Therapeutic Drug Monitoring?
2. Approximate confidence limit for the reference scaled bioequivalence with a parallel design.
3. Pharmacokinetic evaluation and relative bioavailability pilot study of fidaxomicin in healthy Chinese subjects: An open, randomized, single-dose, cross-over study.
4. Generic lamotrigine extended-release tablets are bioequivalent to innovator drug in fully replicated crossover bioequivalence study.
5. Converging Generic Drug Product Development: Bioequivalence Design and Reference Product Selection.
6. A crossover study to evaluate the pharmacokinetics and bioequivalence of hydroxychloroquine tablets in healthy Chinese subjects.
7. Implementation of a reference-scaled average bioequivalence approach for highly variable generic drug products of atorvastatin in Chinese subjects
.
8. Generics in transplantation medicine: Randomized comparison of innovator and substitution products containing mycophenolate mofetil
.
9. A comparison of the intrasubject variation in drug exposure between generic and brand-name drugs: a retrospective analysis of replicate design trials.
10. Application of the 3Rs principles in the development of pharmaceutical generics.